source
- Pathos AI secures $237M Series E funding at $3B valuation, partners with Bristol Myers on neurosciencePathos AI, an AI-focused biotech based in New York, announced it has closed a Series E financing round raising $237 million. The round values the company at $3 billion, reflecting investor confide…
- Warp Sciences raises $215 million Series A to apply AI in drug building-block designFormer OpenAI head of science Kevin Weil announced the launch of Warp Sciences, a new startup aimed at accelerating the creation of molecular building blocks for drug discovery. The company secure…